FOOD manufacturer Weetabix has announced changes to its executive team.
Managing director Sally Abbott is moving to a strategic adviser role from October 1 ahead of her planned retirement at the end of March next year.
She will be replaced by Weetabix’s current commercial director Colm O’Dwyer.
“It has been an incredible journey leading this remarkable company and I am immensely proud of what we have accomplished together,” said Sally.
“Colm has been an integral part of our executive team, demonstrating exceptional leadership and a deep commitment to our company’s values and vision. I have full confidence in Colm’s ability to guide Weetabix into its next phase of growth.”
Her successor has been part of the Weetabix management team at its Burton Latimer headquarters since 2015.
“I have seen first-hand the dedication and talent that drives our success,” Colm said.
“Sally is an exceptional leader who is part of the fabric of Weetabix and leaves the business in excellent shape. Together with the brilliant team that Sally has built, I look forward to leading us into the next chapter of our journey.”
